Health insurance, endogenous medical progress, health expenditure growth, and welfare.

Health care spending Health insurance Intergenerational externality Medical progress Moral hazard Overlapping generations

Journal

Journal of health economics
ISSN: 1879-1646
Titre abrégé: J Health Econ
Pays: Netherlands
ID NLM: 8410622

Informations de publication

Date de publication:
Jan 2023
Historique:
received: 01 07 2021
revised: 23 11 2022
accepted: 08 12 2022
pubmed: 14 1 2023
medline: 25 1 2023
entrez: 13 1 2023
Statut: ppublish

Résumé

We study the impact of health insurance expansion on medical spending, longevity and welfare in an OLG economy in which individuals purchase health care to lower mortality and medical progress is profit-driven. Three sectors are considered: final goods production; a health care sector, selling medical services to individuals; and an R&D sector, selling increasingly effective medical technology to the health care sector. We calibrate the model to the development of the US economy/health care system from 1965 to 2005 and study numerically the impact of the insurance expansion. We find that more extensive health insurance accounts for a large share of the rise in US health spending but also boosts the rate of medical progress. A welfare analysis shows that while the subsidization of health care through health insurance creates excessive health care spending, the gains in life expectancy brought about by induced medical progress more than compensate for this.

Identifiants

pubmed: 36638641
pii: S0167-6296(22)00131-X
doi: 10.1016/j.jhealeco.2022.102717
pii:
doi:

Types de publication

Journal Article

Langues

eng

Pagination

102717

Informations de copyright

Copyright © 2022 The Authors. Published by Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Ivan Frankovic (I)

Deutsche Bundesbank, Germany. Electronic address: ivan.frankovic@bundesbank.de.

Michael Kuhn (M)

International Institute for Applied Systems Analysis (IIASA), Austria; Wittgenstein Centre (IIASA, OeAW, University of Vienna), Austria. Electronic address: kuhn@iiasa.ac.at.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH